Qin Kenan, Ehrmann David A, Cox Nancy, Refetoff Samuel, Rosenfield Robert L
Department of Pediatrics, Section of Pediatric Endocrinology, The University of Chicago, Chicago, Illinois 60637, USA.
J Clin Endocrinol Metab. 2006 Jan;91(1):270-6. doi: 10.1210/jc.2005-2012. Epub 2005 Nov 1.
Polycystic ovary syndrome (PCOS) is characterized by chronic hyperandrogenic anovulation and is associated with insulin resistance. Its pathogenesis is believed to be multifactorial, and abnormal gene regulation could be one contributing factor. Type 5 17beta-hydroxysteroid dehydrogenase (17beta-HSD5) appears to be the major testosterone-forming 17beta-HSD isoenzyme in females.
Our objective was to investigate the role of a potentially activating 17beta-HSD5 gene (HSD17B5) variant in hyperandrogenism.
We conducted a case study and case-control cohort study in our General Clinical Research Center.
Subjects included a case of PCOS who had hyperthecosis associated with profound type B insulin resistance and an unusual, frankly male testosterone response to a GnRH agonist test, as well as 121 PCOS patients and 128 population controls.
Interventions were diagnostic.
Main outcome measures included sequencing of HSD17B5 5'-flanking region and nine exons, genotype/phenotype studies, and in vitro functional studies.
Our case had a previously undescribed homozygous HSD17B5 variant (G-to-A substitution) -71 bp in the promoter region. Genotyping controls showed this to be a single-nucleotide polymorphism (SNP)-71G. Luciferase activity of a SNP-71G promoter construct was significantly higher than that of the wild type, and EMSAs revealed that SNP-71G possessed significantly increased affinity to nuclear transcription factors. SNP-71G allele frequency (32.2 vs. 22.3%) and SNP-71G allele presence (53.7% vs. 38.3%) were significantly increased in PCOS (P = 0.01) [corrected] SNP-71G homozygosity tended to contribute about 20% to the plasma testosterone level.
SNP-71G is a functional polymorphism that may contribute to testosterone excess in a subset of PCOS patients.
多囊卵巢综合征(PCOS)的特征为慢性高雄激素血症性无排卵,并与胰岛素抵抗相关。其发病机制被认为是多因素的,基因调控异常可能是一个促成因素。5型17β-羟基类固醇脱氢酶(17β-HSD5)似乎是女性体内主要的睾酮生成17β-HSD同工酶。
我们的目的是研究一种潜在激活的17β-HSD5基因(HSD17B5)变异在高雄激素血症中的作用。
我们在综合临床研究中心进行了一项病例研究和病例对照队列研究。
研究对象包括1例患有与严重B型胰岛素抵抗相关的卵泡膜细胞增生症且对促性腺激素释放激素(GnRH)激动剂试验有异常、明显男性化睾酮反应的PCOS患者,以及121例PCOS患者和128名人群对照。
干预措施为诊断性的。
主要观察指标包括HSD17B5 5'侧翼区和9个外显子的测序、基因型/表型研究以及体外功能研究。
我们的病例在启动子区域有一个先前未描述的纯合HSD17B5变异(G到A替换)-71 bp。对对照进行基因分型显示这是一个单核苷酸多态性(SNP)-71G。SNP-71G启动子构建体的荧光素酶活性显著高于野生型,电泳迁移率变动分析(EMSA)显示SNP-71G与核转录因子的亲和力显著增加。PCOS患者中SNP-71G等位基因频率(32.2%对22.3%)和SNP-71G等位基因存在率(53.7%对38.3%)显著增加(P = 0.01)[校正后]。SNP-71G纯合性倾向于对血浆睾酮水平贡献约20%。
SNP-71G是一种功能性多态性,可能导致一部分PCOS患者睾酮过量。